Recent initiations
BioAlliance Pharma
Stand and de-Liva
Outlook | Pharmaceutical & Healthcare | 18/06/2013 ...
STV Group
Leveraging Scottish content
Outlook | Media | 18/06/2013 ...
JPMorgan Global Convertibles Income Fund
A different option comes to market
Review | Investment Companies | 13/06/2013 ...
Rubicon
Lord of the rings
Outlook | Construction & Building Materials | 12/06/2013 ...
Edison Insight
May 2013 Edition of Edison Insight
Monthly book | All sectors | 31/05/2013
NYSE Alternext
NYSE Alternext Half Year-Review, June 2013
Sector commentary | All sectors | 10/06/2013
Press releases More
Edison expands French healthcare sector coverage with initiation of coverage on BioAlliance Pharma
Edison has today published a comprehensive report examining the investment merits of BioAlliance Pharma, focusing in particular on the potential of its lead product, Livatag, for hepatocellular carcinoma. Livatag is in a Phase III study, RELIVE, which is expected to render final results in 2016. The report identifies a number of earlier catalysts, including the potential partnering of Sitavig for cold sores, which was approved by the FDA in April 2013 More
Edison and NYSE Alternext extend partnership
Edison Investment Research and NYSE Alternext are pleased to announce the release of Edison’s NYSE Alternext Half-Year Review, which profiles 150 companies listed on the exchange. In response to market feedback, Edison has extended the scope of the analysis, with each profile providing a snapshot of each company’s activities, strategy, recent financial performance and a comment on valuation. More
Latest ResearchMore
Severfield-Rowen
Greater stability creates platform for progress
Update | Engineering | 19/06/2013
Ariana Resources
Funded through to construction
Update | Mining | 19/06/2013
Stratec Biomedical
Taken at the flood
Update | Pharmaceutical & Healthcare | 19/06/2013
Invesco Asia Trust
Look to the long term
Update | Investment Trusts | 18/06/2013
The Quarto Group, Inc.
On track
Update | Media | 18/06/2013
Majestic Wine
Glass half full
QuickView | General Retailers | 18/06/2013
Share plc
Good start to year continues/new CEO
Flash note | Financials | 18/06/2013
BioAlliance Pharma
Stand and de-Liva
Outlook | Pharmaceutical & Healthcare | 18/06/2013
STV Group
Leveraging Scottish content
Outlook | Media | 18/06/2013
Carador Income Fund
US corporate loans via CLOs
Update | Investment Companies | 17/06/2013
Resverlogix
Pure play on ASSURE
QuickView | Pharmaceutical & Healthcare | 14/06/2013
Epigenomics
Going head-to-head with Exact
Update | Pharmaceutical & Healthcare | 14/06/2013
Oncolytics Biotech Inc
Promising melanoma and lung cancer data
Update | Pharmaceutical & Healthcare | 14/06/2013
Wilex
Density and destiny
Update | Pharmaceutical & Healthcare | 14/06/2013
Edison TVMore
Sector commentaryMore
Awards More
Awarded winner of international investment research advisory firm of the year
Alex Gregory is a leading rower in the Great Britain rowing team, having recently stroked the renowned GB coxless four to gold at the London 2012 Olympic Games. Read more »
Follow commentary from All Black Leon MacDonald and Sky Sport Rugby commentator Scotty Stevenson, on this year's Lions Tour. Read more »